ES2176263T3 - 5,6-dihidropironas derivadas como inhibidores de proteasa y agentes antivirus. - Google Patents

5,6-dihidropironas derivadas como inhibidores de proteasa y agentes antivirus.

Info

Publication number
ES2176263T3
ES2176263T3 ES94932030T ES94932030T ES2176263T3 ES 2176263 T3 ES2176263 T3 ES 2176263T3 ES 94932030 T ES94932030 T ES 94932030T ES 94932030 T ES94932030 T ES 94932030T ES 2176263 T3 ES2176263 T3 ES 2176263T3
Authority
ES
Spain
Prior art keywords
dihydropironas
derived
antivirus agents
proteasa
inhibitors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94932030T
Other languages
English (en)
Inventor
Edmund Lee Ellsworth
Elizabeth Lunney
Bradley Dean Tait
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Parke Davis and Co LLC
Original Assignee
Parke Davis and Co LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/319,821 external-priority patent/US5789440A/en
Application filed by Parke Davis and Co LLC filed Critical Parke Davis and Co LLC
Application granted granted Critical
Publication of ES2176263T3 publication Critical patent/ES2176263T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C321/00—Thiols, sulfides, hydropolysulfides or polysulfides
    • C07C321/24—Thiols, sulfides, hydropolysulfides, or polysulfides having thio groups bound to carbon atoms of six-membered aromatic rings
    • C07C321/26—Thiols
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/10—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C323/18—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton
    • C07C323/20—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton with singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/22—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and doubly-bound oxygen atoms bound to the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/86—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/32—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/96—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings spiro-condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/10—Systems containing only non-condensed rings with a five-membered ring the ring being unsaturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/16—Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Pyrane Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE A DERIVADOS 5,6-DIHIDROPIRONA NUEVOS Y ESTRUCTURAS RELACIONADAS QUE INHIBEN POTENTEMENTE LA PROTEASA ASPARTIL DE VIH QUE BLOQUEA LA INFECCION DEL VIH. DICHOS DERIVADOS SON UTILES EN EL DESARROLLO DE TERAPIAS PARA EL TRATAMIENTO DE ENFERMEDADES E INFECCIONES VIRALES Y BACTERIALES, INCLUYENDO EL SIDA. LA PRESENTE INVENCION TAMBIEN SE REFIERE A METODOS DE SINTESIS DE 5,6,DIHIDROPIRONAS MULTIFUNCIONALIZADAS Y ESTRUCTURAS RELACIONADAS.
ES94932030T 1993-11-19 1994-10-26 5,6-dihidropironas derivadas como inhibidores de proteasa y agentes antivirus. Expired - Lifetime ES2176263T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US15544393A 1993-11-19 1993-11-19
US08/319,821 US5789440A (en) 1993-11-19 1994-10-12 5,6-dihydropyrone derivatives as protease inhibitors and antiviral agents

Publications (1)

Publication Number Publication Date
ES2176263T3 true ES2176263T3 (es) 2002-12-01

Family

ID=26852339

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94932030T Expired - Lifetime ES2176263T3 (es) 1993-11-19 1994-10-26 5,6-dihidropironas derivadas como inhibidores de proteasa y agentes antivirus.

Country Status (27)

Country Link
US (1) US5936128A (es)
EP (1) EP0729463B1 (es)
JP (1) JP3698435B2 (es)
AT (1) ATE217871T1 (es)
AU (1) AU680064B2 (es)
BG (1) BG63012B1 (es)
CA (1) CA2176041A1 (es)
CZ (1) CZ291856B6 (es)
DE (1) DE69430671T2 (es)
DK (1) DK0729463T3 (es)
EE (1) EE9600045A (es)
ES (1) ES2176263T3 (es)
FI (1) FI962021A7 (es)
HR (1) HRP940936B1 (es)
HU (1) HUT75225A (es)
IL (1) IL111673A (es)
MD (2) MD1560F2 (es)
NO (1) NO315117B1 (es)
NZ (1) NZ275318A (es)
PL (1) PL180634B1 (es)
PT (1) PT729463E (es)
RO (1) RO117850B1 (es)
RU (1) RU2160733C2 (es)
SI (1) SI0729463T1 (es)
SK (1) SK283240B6 (es)
TJ (1) TJ320B (es)
WO (1) WO1995014011A2 (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0862651A2 (en) * 1995-10-16 1998-09-09 Chiron Corporation Method of screening for factors that modulate gene expression
DK0861085T3 (da) 1995-11-13 2005-11-21 Vitaleech Bioscience N V Antivirale isolater opnået fra igler
US5834506A (en) * 1996-11-01 1998-11-10 Warner-Lambert Company Dihydropyrones with improved antiviral activity
US6087455A (en) * 1997-12-19 2000-07-11 Shell Oil Company Process for hydrogenation of macromolecular organic substrates
BR9913598A (pt) * 1998-09-11 2001-05-29 Warner Lambert Co Inibidores de protease de hiv
DE10030094A1 (de) 2000-06-19 2001-12-20 Bayer Ag Phenylsubstituierte 5,6-Dihydro-pyron-Derivate
DE10100175A1 (de) * 2001-01-04 2002-07-11 Bayer Ag Hetarylsubstituierte Homotetram-und Homotetronsäuren
DOP2003000641A (es) 2002-05-10 2003-11-15 Pfizer Inhibidores de las arn polimerasa dependiente de arn del virus de las hepatitis c y composiciones y tratamiento que los usan
US7148226B2 (en) 2003-02-21 2006-12-12 Agouron Pharmaceuticals, Inc. Inhibitors of hepatitis C virus RNA-dependent RNA polymerase, and compositions and treatments using the same
GEP20094751B (en) 2004-08-18 2009-08-10 Pfizer Inhibitors of hepatitis c virus rna-dependent rna polymerase, and compositions and treatments using the same
CN101225066B (zh) * 2007-01-18 2010-09-22 国鼎生物科技股份有限公司 牛樟芝的环己烯酮萃取物
WO2009126305A1 (en) * 2008-04-11 2009-10-15 The Trustees Of Columbia University Glucose metabolism modulating compounds
EP3068416A4 (en) 2013-11-11 2017-08-09 Kuality Herbceutics LLC Kava derived therapeutic compounds and methods of use thereof
US10584108B2 (en) 2015-05-07 2020-03-10 Kuality Herbceutics Llc Therapeutic compounds and methods of use thereof
KR102521955B1 (ko) * 2016-06-14 2023-04-13 브리스톨-마이어스 스큅 컴퍼니 Apj 수용체 효능제로서의 4-히드록시-3-술포닐피리딘-2(1h)-온
RU2019114964A (ru) 2016-10-17 2020-11-17 Дженентек, Инк. Терапевтические средства и способы их применения
GB201707856D0 (en) 2017-05-16 2017-06-28 Arctic Pharma As Compounds

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3206276A (en) * 1961-09-28 1965-09-14 Minerals Engineering Company Process for recovery of pure v2o5 from vanadium bearing materials
US3206476A (en) * 1962-06-04 1965-09-14 Sterling Drug Inc 3-substituted-4-hydroxy-6-aryl-2-pyrones and preparation
US3931235A (en) * 1972-12-18 1976-01-06 The Dow Chemical Company Process for preparing sulfur-containing hydroxy pyrones
US3818046A (en) * 1972-12-18 1974-06-18 Dow Chemical Co Sulfur-containing hydroxy pyrones and alkali metal salts thereof
MA21177A1 (fr) * 1987-02-11 1988-10-01 May & Baker Ltd Diones cycliques.
AU4074789A (en) * 1988-03-01 1989-09-22 Upjohn Company, The Coumarins to inhibit reverse transcriptase in humans
JPH03227923A (ja) * 1990-01-30 1991-10-08 Sawai Seiyaku Kk ひと免疫不全ウイルス疾患処置剤
CA2121363A1 (en) * 1991-11-18 1993-05-27 Mehrdad Badie User selectable noise cancelling for portable microphones
ZA938019B (en) * 1992-11-13 1995-04-28 Upjohn Co Pyran-2-ones and 5,6-dihydropyran-2-ones useful for treating HIV and other retroviruses
IL108459A0 (en) * 1993-02-05 1994-04-12 Opjohn Company 4-Hydroxy-benzopyran-2-ones and 4-hydroxy-cycloalkyl [B] pyran-2-ones useful for treating infections due to hiv and other retroviruses

Also Published As

Publication number Publication date
JP3698435B2 (ja) 2005-09-21
HUT75225A (en) 1997-04-28
MD1560F2 (en) 2000-11-30
BG63012B1 (bg) 2001-01-31
FI962021L (fi) 1996-07-12
ATE217871T1 (de) 2002-06-15
MD1560G2 (ro) 2001-07-31
IL111673A (en) 1999-04-11
WO1995014011A2 (en) 1995-05-26
SK64696A3 (en) 1997-03-05
DE69430671D1 (de) 2002-06-27
AU8090094A (en) 1995-06-06
DE69430671T2 (de) 2002-11-21
CZ136896A3 (en) 1997-12-17
PL314483A1 (en) 1996-09-16
RO117850B1 (ro) 2002-08-30
JPH09505292A (ja) 1997-05-27
TJ320B (en) 2001-10-22
FI962021A7 (fi) 1996-07-12
EP0729463A1 (en) 1996-09-04
US5936128A (en) 1999-08-10
NZ275318A (en) 1999-06-29
HU9601349D0 (en) 1996-07-29
NO962018L (no) 1996-07-04
SI0729463T1 (en) 2002-08-31
FI962021A0 (fi) 1996-05-13
EE9600045A (et) 1996-10-15
PT729463E (pt) 2002-10-31
CA2176041A1 (en) 1995-05-26
SK283240B6 (sk) 2003-04-01
HRP940936A2 (en) 1997-08-31
NO962018D0 (no) 1996-05-15
AU680064B2 (en) 1997-07-17
MD960172A (en) 1999-01-31
BG100563A (bg) 1996-12-31
IL111673A0 (en) 1995-01-24
NO315117B1 (no) 2003-07-14
WO1995014011A3 (en) 1995-06-29
EP0729463B1 (en) 2002-05-22
PL180634B1 (pl) 2001-03-30
DK0729463T3 (da) 2002-09-09
HRP940936B1 (en) 2003-12-31
RU2160733C2 (ru) 2000-12-20
CZ291856B6 (cs) 2003-06-18

Similar Documents

Publication Publication Date Title
ES2176263T3 (es) 5,6-dihidropironas derivadas como inhibidores de proteasa y agentes antivirus.
PT1142887E (pt) Derivados de 5,6-di-hidropirona como inibidores de protease e agentes antivirais
ES2177868T3 (es) Hidroxietilaminosulfonamidas de alfa- y beta-aminoacidos utiles como inhibidores de proteasas retroviricas.
ES2125251T3 (es) Inhibidores de la proteasa del vih.
AU2003291998A8 (en) Method and compositions for identifying anti-hiv therapeutic compounds
ES2174921T3 (es) Inhibidores de la proteasa del vih.
ES2191035T3 (es) Derivados de la pirona como inhibidores de la proteasa y agentes antiviricos.
ATE295838T1 (de) Benzimidazolderivate zur behandlung von mit mikroglia-aktivierung assoziierten erkrankungen wie inflammatorische, allergische, infektiöse oder autoimmune erkrankungen
DE69332904D1 (de) Hemmung von hiv-infektion
AR029855A1 (es) Formas de sal de un inhibidor de la proteasa del hiv
ES2190456T3 (es) Combinacion de inhibidores de la proteasa del vih.
ATE212839T1 (de) Hämoregulatorische verbindungen
ES2072431T3 (es) D-acido aspartico beta-hidroxamato para el tratamiento de infecciones virales y de tumores.
ECSP993132A (es) Inhibidores de hiv proteasa